Use of THC/CBD has the potential to generate cost savings by significantly improving the symptoms of moderate to severe MS spasticity.
Link: A Cost-effectiveness Model For The Use Of A Cannabis-derived Oromucosal Spray For The Treatment Of Spasticity In Multiple Sclerosis
Year: 2016
Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.
(THC/CBD) oromucosal spray